We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » MONTANA CRITICIZED FOR POOR MEDICAID DRUG REBATE CONTROLS
MONTANA CRITICIZED FOR POOR MEDICAID DRUG REBATE CONTROLS
December 30, 2003
Montana Medicaid administrators need to better control the collection of rebates from drug manufacturers and improve the state’s accounts receivable system, according to a recent audit released by the HHS Office of Inspector General (OIG).